Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Different people show different symptoms for genetic diseases because of how sensitive their bodies are to small changes in important factors.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Tph cells are linked to the severity of systemic lupus erythematosus.

The assay effectively identifies compounds that affect immune cell activation.

The new skin model can predict how chemicals might cause skin allergies.

Atopic dermatitis affects the appearance of skin reactions, making certain features more common and improving diagnostic accuracy with dermoscopy.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

γδ T cells adapt uniquely to different tissues in mice.

Live imaging helps us understand skin immune responses and develop treatments.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.